QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal Panel tests for clinical use. This clearance by ...
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal ...
Zacks.com on MSN5 个月
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and PanelsQIAGEN N.V.’s QGEN QIAstat-Dx syndromic testing systems and associated assays have earned CE-marking under the European Union ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈